Long-term oral administration of taurine for 52 weeks effectively reduced stroke-like episode recurrence in MELAS syndrome patients.

“long-term oral administration of torine for 52 weeks effectively reduce the recurrence of stroke like episodes in mitochondrial myopathy enop lactic aidos acidosis and stroke like episodes which is known as the melas syndrome rare genetic disorder”